Skip to content
Homepage
Author:
Lungpacer Medical USA Inc.
Posted Date:
July 22, 2026
Lungpacer Announces New Category III CPT® Codes for AeroPace® Diaphragm Neurostimulation Therapy
Lungpacer Medical USA Inc.
July 22, 2026
Lungpacer Medical Announces Presentation of DONATE Data Reporting an Increase in Availability of Donor Lungs
Lungpacer Medical USA Inc.
June 23, 2026
Lungpacer Medical Appoints Steven Pfanstiel as Chief Financial Officer
Lungpacer Medical USA Inc.
June 1, 2026
